Joo-Won Nam

Prof. Joo-Won Nam

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2018 in Natural Product Reports
Verified
Journal Article
Open access
PDF file
JMJames B. McAlpine
James B. McAlpine
SCShao-Nong Chen
Shao-Nong Chen
AKAndrei G. Kutateladze
Andrei G. Kutateladze
JMJohn B MacMillan
John B MacMillan
Giovanni AppendinoGiovanni Appendino
Giovanni Appendino
GPGuido F. Pauli
Guido F. Pauli
With contributions from the global natural product (NP) research community, and continuing the Raw Data Initiative, this review collects a comprehensive demonstration of the immense scientific value of disseminating raw nuclear magnetic resonance (NMR) data, independently of, and in parallel with, classical publishing outlets.

5 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMahesh Pandit
Mahesh Pandit
YKYun-Seo Kil
Yun-Seo Kil
JAJae-Hee Ahn
Jae-Hee Ahn
RPRam Hari Pokhrel
Ram Hari Pokhrel
YGYe Gu
Ye Gu
JCJae-Hoon Chang
Jae-Hoon Chang
Programmed cell death protein 1 (PD-1), expressed on tumor-infiltrating T cells, is a T cell exhaustion marker. The mechanisms underlying PD-1 upregulation in CD4 T cells remain unknown. Here we develop nutrient-deprived media and a conditional knockout female mouse model to study the mechanism underlying PD-1 upregulation. Reduced methionine increases PD-1 expression on CD4 T cells. The genetic ablation of SLC43A2 in cancer cells restores methionine metabolism in CD4 T cells, increasing the intracellular levels of S-adenosylmethionine and yielding H3K79me2. Reduced H3K79me2 due to methionine deprivation downregulates AMPK, upregulates PD-1 expression and impairs antitumor immunity in CD4 T cells. Methionine supplementation restores H3K79 methylation and AMPK expression, lowering PD-1 levels. AMPK-deficient CD4 T cells exhibit increased endoplasmic reticulum stress and Xbp1s transcript levels. Our results demonstrate that AMPK is a methionine-dependent regulator of the epigenetic control of PD-1 expression in CD4 T cells, a metabolic checkpoint for CD4 T cell exhaustion.

1 February 2019 in Dental Materials
Verified
Journal Article
Closed access
BABerdan Aydin
Berdan Aydin
ALAriene A. Leme-Kraus
Ariene A. Leme-Kraus
CVCristina M.P. Vidal
Cristina M.P. Vidal
TAThaiane R. Aguiar
Thaiane R. Aguiar
RPRasika S. Phansalkar
Rasika S. Phansalkar
ABAna K. Bedran-Russo
Ana K. Bedran-Russo

19 November 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MSMi-rae Shin
Mi-rae Shin
JLJin A Lee
Jin A Lee
MKMin Ju Kim
Min Ju Kim
SLSehui Lee
Sehui Lee
MOMinhyuck Oh
Minhyuck Oh
Seong-Soo RohSeong-Soo Roh
Seong-Soo Roh
Liver fibrosis, which means a sort of the excessive accumulation of extracellular matrices (ECMs) components through the liver tissue, is considered as tissue repair or wound-healing status. This pathological stage potentially leads to cirrhosis, if not controlled, it progressively results in hepatocellular carcinoma. Herein, we investigated the pharmacological properties and underlying mechanisms of Gardeniae Fructus (GF) against thioacetamide (TAA)-induced liver fibrosis of mice model. GF not only attenuated hepatic tissue oxidation but also improved hepatic inflammation. We further confirmed that GF led to ameliorating liver fibrosis by ECMs degradations. Regarding the possible underlying mechanism of GF, we observed GF regulated epigenetic regulator, Sirtuin 1 (SIRT1), in TAA-injected liver tissue. These alterations were well supported by SIRT1 related signaling pathways through regulations of its downstream proteins including, AMP-activated protein kinase (AMPK), p47phox, NADPH oxidase 2, nuclear factor erythroid 2–related factor 2 (Nrf2), and heme oxygenase-1, respectively. To validate the possible mechanism of GF, we used HepG2 cells with hydrogen peroxide treated oxidative stress and chronic exposure conditions via deteriorations of cellular SIRT1. Moreover, GF remarkably attenuated ECMs accumulations in transforming growth factor–β1-induced LX-2 cells relying on the SIRT1 existence. Taken together, GF attenuated liver fibrosis through AMPK/SIRT1 pathway as well as Nrf2 signaling cascades. Therefore, GF could be a clinical remedy for liver fibrosis patients in the future.

21 September 2017 in Molecules
Verified
Journal Article
Open access
PDF file
SLSeulah Lee
Seulah Lee
DLDahae Lee
Dahae Lee
TJTae Su Jang
Tae Su Jang
Ki Sung  KangKi Sung Kang
Ki Sung Kang
Joo-Won NamJoo-Won Nam
Joo-Won Nam
Ki Hyun KimKi Hyun Kim
Ki Hyun Kim
The edible fungus Phellinus baumii Pilat (Hymenochaetaceae) has been used in Korean traditional medicines for strengthening health and prolonging life. An extract of the fruiting bodies of P. baumii was subjected to bioassay-guided fractionation based on its anti-inflammatory effects in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. The resulting fractions were chemically investigated, leading to isolation of three phenolic compounds (1–3), a sesquiterpene (4), two steroids (5–6), a fatty acid (7), and a cerebroside (8). Spectroscopic analyses including 1D and 2D NMR spectroscopy and LC/MS were used to determine their chemical structures. Compounds 2, 4, 5, 7 and 8 were identified in P. baumii for the first time. Since all compounds were isolated from active fractions with anti-inflammatory activity, their ability to inhibit LPS-stimulated nitric oxide (NO) production in RAW264.7 cells were evaluated in vitro. Compounds 1, 2, 3, 5 and 7 inhibited LPS-stimulated NO production, and compounds 1–3 had IC50 values <10 μM. Treatment of LPS-stimulated RAW264.7 cells with compounds 1–3 inhibited phosphorylation of IKKα and IκBα. In addition, treatment of compounds 1–3 reduced LPS-induced increases of nuclear factor-kappa B (NF-κB) p65, iNOS and COX-2 protein expressions. Collectively, compounds 1–3 inhibited NF-κB-dependent inflammation in RAW264.7 cells. Thus, P. baumii is a potential source of natural anti-inflammatory agents, and active compounds 1–3 could be promising lead compounds for the development of novel anti-inflammatory agents.

23 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
BKBo-Ram Kim
Bo-Ram Kim
SPSunil Paudel
Sunil Paudel
Joo-Won NamJoo-Won Nam
Joo-Won Nam
CJChang Hyun Jin
Chang Hyun Jin
Ik-Soo LeeIk-Soo Lee
Ik-Soo Lee
AHAh-Reum Han
Ah-Reum Han
A new polyacetylene glycoside, (5R)-6E-tetradecene-8,10,12-triyne-1-ol-5-O-β-glucoside (1), was isolated from the flower of Coreopsis lanceolata (Compositae), together with two known compounds, bidenoside C (10) and (3S,4S)-5E-trideca-1,5-dien-7,9,11-triyne-3,4-diol-4-O-β-glucopyranoside (11), which were found in Coreopsis species for the first time. The other known compounds, lanceoletin (2), 3,2′-dihydroxy-4-3′-dimethoxychalcone-4′-glucoside (3), 4-methoxylanceoletin (4), lanceolin (5), leptosidin (6), (2R)-8-methoxybutin (7), luteolin (8) and quercetin (9), were isolated in this study and reported previously from this plant. The structure of 1 was elucidated by analyzing one-dimensional and two-dimensional nuclear magnetic resonance and high resolution-electrospray ionization-mass spectrometry data. All compounds were tested for their dipeptidyl peptidase IV (DPP-IV) inhibitory activity and compounds 2–4, 6 and 7 inhibited DPP-IV activity in a concentration-dependent manner, with IC50 values from 9.6 to 64.9 μM. These results suggest that C. lanceolata flower and its active constituents show potential as therapeutic agents for diseases associated with type 2 diabetes mellitus.